Bipin Shah – Owner - ANUH PHARMA LTD of Anuh Pharma
View Detailed Executive Profile →Professional Overview
- Bipin N. Shah serves as the Vice Chairman of Anuh Pharma Ltd., a prominent position that underscores his leadership role within the organization.
- As a qualified Chemical Engineer, Bipin Shah has leveraged his technical expertise to drive innovation and operational excellence in the pharmaceutical manufacturing sector.
- Under Bipin Shah's leadership, Anuh Pharma constructed a world-class manufacturing facility, significantly enhancing the company's production capabilities and efficiency.
- In the year 2000, Anuh Pharma became the largest manufacturer of erythromycin, a notable achievement that reflects the company's growth trajectory and market leadership in the pharmaceutical industry.
- Bipin Shah has been instrumental in the strategic expansion of Anuh Pharma, focusing on increasing production capacity to meet growing global demand for pharmaceutical products.
- As a member of the Board of Directors at Anuh Pharma, Bipin Shah contributes to high-level decision-making processes that shape the company's strategic direction and governance.
- His tenure at Anuh Pharma has been marked by a commitment to quality and compliance, ensuring that the company adheres to stringent regulatory standards in pharmaceutical manufacturing.
- Bipin Shah's leadership style emphasizes collaboration and innovation, fostering a corporate culture that encourages employee engagement and continuous improvement.
- Through his vision and strategic initiatives, Bipin Shah has positioned Anuh Pharma as a key player in the global pharmaceutical market, enhancing its reputation and competitive edge.
- Bipin Shah's contributions extend beyond operational management; he is also involved in mentoring emerging leaders within the organization, promoting professional development and succession planning.
- His active participation in industry forums and associations reflects a commitment to advancing the pharmaceutical sector and sharing best practices with peers.
- Bipin Shah's focus on sustainability and ethical practices in manufacturing has contributed to Anuh Pharma's reputation as a socially responsible organization.
- Throughout his career, Bipin Shah has been recognized for his contributions to the pharmaceutical industry, earning accolades that highlight his impact and leadership.
- His strategic foresight has enabled Anuh Pharma to navigate market challenges effectively, ensuring resilience and adaptability in a dynamic industry landscape.
- Bipin Shah's ongoing commitment to research and development has facilitated the introduction of innovative products, further solidifying Anuh Pharma's market position.
Professional Experience
| Company | Designation | Period |
|---|---|---|
| PLUTONIUM BUSINESS SOLUTION PRIVATE LIMITED | Managing Director | 16-Dec-1985 – 03-Feb-2012 |
| PLUTONIUM BUSINESS SOLUTION PRIVATE LIMITED | Director | 03-Feb-2012 – 18-Feb-2019 |
| CHAITANYA LIFE SCIENCE PRIVATE LIMITED | Additional Director | 01-Jun-2021 – 30-Nov-2021 |
| FRANCO INDIAN MEDICARE PVT LTD | Director | 01-Dec-1993 – 21-Jul-2008 |
| ANUH PHARMA LIMITED | Managing Director | 01-Apr-2009 – 07-Jan-2021 |
| ANUH PHARMA LTD | Owner | Present |
| CHAITANYA LIFE SCIENCE PRIVATE LIMITED | Director | 30-Nov-2021 – Present |
| ITAL PHARCHEM PRIVATE LIMITED | Director | 20-Sep-2012 – Present |
| ESKAY IODINE PRIVATE LIMITED | Director | 19-Oct-2011 – Present |
| ANUH PHARMA LIMITED | Director | 08-Jan-2021 – Present |
Current Appointments
| CIN/LLP | Company | Designation | Date |
|---|---|---|---|
| L24230MH1960PLC011586 | ANUH PHARMA LIMITED | Director | 08-Jan-2021 |
| U24100MH2011PTC221911 | ESKAY IODINE PRIVATE LIMITED | Director | 19-Oct-2011 |
| U24230GJ2010PTC060902 | CHAITANYA LIFE SCIENCE PRIVATE LIMITED | Director | 30-Nov-2021 |
| U51101MH2012PTC236003 | ITAL PHARCHEM PRIVATE LIMITED | Director | 20-Sep-2012 |
Previous Appointments
| CIN/LLP | Company | Designation | Period |
|---|---|---|---|
| L24230MH1960PLC011586 | ANUH PHARMA LIMITED | Managing Director | 01-Apr-2009 – 07-Jan-2021 |
| U24230GJ2010PTC060902 | CHAITANYA LIFE SCIENCE PRIVATE LIMITED | Additional Director | 01-Jun-2021 – 30-Nov-2021 |
| U24231WB1983PTC036434 | FRANCO INDIAN MEDICARE PVT LTD | Director | 01-Dec-1993 – 21-Jul-2008 |
| U45100MH1983PTC030195 | PLUTONIUM BUSINESS SOLUTION PRIVATE LIMITED | Director | 03-Feb-2012 – 18-Feb-2019 |
| U45100MH1983PTC030195 | PLUTONIUM BUSINESS SOLUTION PRIVATE LIMITED | Managing Director | 16-Dec-1985 – 03-Feb-2012 |
Estimated Net Worth
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Anuh Pharma corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Bipin Shah's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Anuh Pharma's official communication channels.
Is this an official profile?
No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)